Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $16.79 $21.30 Thursday, 9th May 2024 KURA stock ended at $20.77. This is 1.10% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.88% from a day low at $20.52 to a day high of $21.11.
90 days $16.79 $24.16
52 weeks $7.41 $24.16

Historical Kura Oncology prices

Date Open High Low Close Volume
May 09, 2024 $20.60 $21.11 $20.52 $20.77 381 005
May 08, 2024 $20.78 $20.88 $20.14 $20.55 507 972
May 07, 2024 $21.00 $21.30 $20.61 $21.07 511 549
May 06, 2024 $20.77 $21.26 $20.70 $21.01 762 080
May 03, 2024 $20.55 $21.25 $20.26 $20.63 593 864
May 02, 2024 $20.15 $20.64 $19.96 $20.59 531 006
May 01, 2024 $19.63 $20.81 $19.63 $20.28 728 317
Apr 30, 2024 $19.92 $20.35 $19.60 $19.62 525 982
Apr 29, 2024 $19.80 $20.34 $19.72 $20.06 459 564
Apr 26, 2024 $19.20 $19.71 $18.95 $19.65 543 365
Apr 25, 2024 $18.26 $19.22 $17.96 $19.00 827 642
Apr 24, 2024 $18.75 $18.92 $18.41 $18.75 634 155
Apr 23, 2024 $18.12 $19.27 $18.12 $18.73 1 018 993
Apr 22, 2024 $18.33 $19.18 $17.92 $18.19 1 985 940
Apr 19, 2024 $17.61 $17.90 $16.79 $17.53 1 329 539
Apr 18, 2024 $17.86 $18.05 $17.54 $17.68 1 520 343
Apr 17, 2024 $18.80 $18.89 $17.89 $17.99 628 865
Apr 16, 2024 $18.81 $18.95 $18.41 $18.59 813 510
Apr 15, 2024 $19.57 $19.70 $18.61 $19.01 693 250
Apr 12, 2024 $20.30 $20.30 $19.00 $19.48 619 533
Apr 11, 2024 $20.04 $20.61 $20.04 $20.40 732 727
Apr 10, 2024 $20.07 $20.24 $19.71 $19.90 854 431
Apr 09, 2024 $20.44 $20.81 $20.00 $20.68 395 882
Apr 08, 2024 $20.65 $20.72 $20.12 $20.42 289 991
Apr 05, 2024 $20.09 $20.80 $19.58 $20.36 599 643
Click to get the best stock tips daily for free!

About Kura Oncology

Kura Oncology Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, includi... KURA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT